C. Nichols
Corporate Officer/Principal chez ALKERMES PLC
Fortune : 2 M $ au 30/04/2024
Postes actifs de C. Nichols
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALKERMES PLC | Corporate Officer/Principal | - | - |
| Sales & Marketing | 13/05/2019 | - |
Historique de carrière de C. Nichols
Anciens postes connus de C. Nichols
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Sales & Marketing | 01/05/2019 | 01/05/2020 |
| CELGENE | Sales & Marketing | 01/01/2018 | 01/01/2019 |
| BIOGEN INC. | Sales & Marketing | - | 01/01/2017 |
Formation de C. Nichols
| Elon University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Irlande | 2 |
Opérationnelle
| Sales & Marketing | 4 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ALKERMES PLC | Health Technology |
| BIOGEN INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- C. Nichols
- Expérience
